Takeda Pharmaceutical Company Limited (TYO:4502)
5,808.00
+11.00 (0.19%)
Aug 25, 2026, 1:55 PM JST
TYO:4502 Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, TYO:4502 stock has a consensus rating of "Buy" and an average price target of ¥6,450. The average 1-year stock price forecast is 11.06% higher than the current stock price, while the lowest is ¥5,600 (-3.58%) and the highest is ¥7,900 (+36.02%).
Price Target: ¥6,450 (+11.06%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TYO:4502 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 6 | 7 | 7 | 7 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 6 | 5 | 5 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates ¥6,000 → ¥6,800 | Buy | Reiterates | ¥6,000 → ¥6,800 | +17.08% | Aug 13, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 7, 2026 |
| Jefferies | Jefferies | Buy Maintains ¥6,800 | Buy | Maintains | ¥6,800 | +17.08% | Jul 29, 2026 |
| Bernstein | Bernstein | Buy Reiterates ¥6,900 | Buy | Reiterates | ¥6,900 | +18.80% | Jul 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates ¥6,200 → ¥6,300 | Buy | Reiterates | ¥6,200 → ¥6,300 | +8.47% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
4.69T
from 4.51T
Increased by 4.00%
Revenue Next Year
4.77T
from 4.69T
Increased by 1.69%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.